Published in Bioconjug Chem on August 01, 2011
Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer. AAPS PharmSciTech (2014) 0.85
Quantum dot-based nanoprobes for in vivo targeted imaging. Curr Mol Med (2013) 0.83
Quantum Dots Encapsulated with Canine Parvovirus-Like Particles Improving the Cellular Targeted Labeling. PLoS One (2015) 0.75
Renal clearance of quantum dots. Nat Biotechnol (2007) 12.54
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (1998) 8.11
Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small (2009) 2.59
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc Natl Acad Sci U S A (2008) 2.55
Time-domain fluorescence lifetime imaging applied to biological tissue. Photochem Photobiol Sci (2004) 1.75
Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn (2006) 1.63
How to stabilize phospholipid liposomes (using nanoparticles). Nano Lett (2006) 1.38
Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm (2009) 1.38
Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX. Cancer (2004) 1.38
Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano Lett (2008) 1.34
Predicting in vivo fluorescence lifetime behavior of near-infrared fluorescent contrast agents using in vitro measurements. J Biomed Opt (2008) 1.18
Time-resolved and two-photon emission imaging microscopy of live cells with inert platinum complexes. Proc Natl Acad Sci U S A (2008) 1.17
Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc (2005) 1.10
In vivo simultaneous monitoring of two fluorophores with lifetime contrast using a full-field time domain system. Appl Opt (2009) 1.07
Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides. J Control Release (2006) 1.00
Hydrogen bonding-enhanced micelle assemblies for drug delivery. Biomaterials (2010) 1.00
Methods for imaging the structure and function of living tissues and cells: 2. Fluorescence lifetime imaging. J Pathol (2000) 0.99
In vitro cytotoxicity evaluation of biomedical nanoparticles and their extracts. J Biomed Mater Res A (2010) 0.99
Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide. Int J Pharm (2008) 0.97
Magnetic resonance and fluorescence imaging of doxorubicin-loaded nanoparticles using a novel in vivo model. Nanomedicine (2010) 0.95
Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity. Nanomedicine (2011) 0.94
A liposomal formulation able to incorporate a high content of Paclitaxel and exert promising anticancer effect. J Drug Deliv (2010) 0.91
Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations. Int J Pharm (2006) 0.91
Acute toxicity of two CdSe/ZnSe quantum dots with different surface coating in Daphnia magna under various light conditions. Environ Toxicol (2010) 0.90
Whole-body, real-time preclinical imaging of quantum dot fluorescence with time-gated detection. J Biomed Opt (2010) 0.89
Bioimaging for targeted delivery of hyaluronic Acid derivatives to the livers in cirrhotic mice using quantum dots. ACS Nano (2010) 0.87
Functionalized near-infrared quantum dots for in vivo tumor vasculature imaging. Nanotechnology (2010) 0.86
Self-assembled hydrogel nanoparticles composed of dextran and poly(ethylene glycol) macromer. Int J Pharm (2000) 0.83
Quantum dot loaded immunomicelles for tumor imaging. BMC Med Imaging (2010) 0.81
Self-exploding lipid-coated microgels. Biomacromolecules (2006) 0.79
A new PEG-lipid conjugate micelle for encapsulation of CdSe/ZnS quantum dots. J Nanosci Nanotechnol (2010) 0.77
In situ spectral imaging of marker proteins in gastric cancer with near-infrared and visible quantum dots probes. Talanta (2011) 0.77
Malignant gliomas in adults. N Engl J Med (2008) 20.54
Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev (2007) 6.00
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol (2008) 5.21
A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (2003) 4.49
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron (2007) 4.47
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med (2004) 4.39
Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A (2011) 3.45
Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques. Bioinformatics (2009) 3.00
Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib. J Clin Oncol (2006) 2.82
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res (2009) 2.74
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc Natl Acad Sci U S A (2008) 2.55
Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study. J Neurosurg (2011) 2.21
Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol (2012) 2.08
Development of NG2 neural progenitor cells requires Olig gene function. Proc Natl Acad Sci U S A (2006) 2.04
MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol (2012) 2.02
Human glioma growth is controlled by microRNA-10b. Cancer Res (2011) 1.96
The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma. Cancer Cell (2011) 1.92
Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J Clin Oncol (2009) 1.92
Autoantigen discovery with a synthetic human peptidome. Nat Biotechnol (2011) 1.90
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab. Neuro Oncol (2009) 1.83
Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. Neuro Oncol (2006) 1.76
Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies. Cancer Res (2011) 1.64
Chemically-selective imaging of brain structures with CARS microscopy. Opt Express (2007) 1.62
A review of standards for data exchange within systems biology. Proteomics (2007) 1.61
Nucleotide polymorphism and phenotypic associations within and around the phytochrome B2 Locus in European aspen (Populus tremula, Salicaceae). Genetics (2008) 1.61
Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci U S A (2008) 1.52
Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma. Neuro Oncol (2012) 1.50
Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article. J Neurosurg (2013) 1.46
Early onset severe pre-eclampsia: expectant management at a secondary hospital in close association with a tertiary institution. BJOG (2005) 1.39
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma. J Neurooncol (2008) 1.39
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres. Genes Cancer (2010) 1.33
Using the heat-shock response to discover anticancer compounds that target protein homeostasis. ACS Chem Biol (2011) 1.31
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro Oncol (2009) 1.30
Brain metastases. Curr Opin Neurol (2005) 1.29
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins. J Clin Invest (2008) 1.29
Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol (2009) 1.27
Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy. PLoS One (2010) 1.27
Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells. J Neurovirol (2006) 1.27
Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol (2011) 1.26
MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS One (2013) 1.25
Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent. AIDS (2011) 1.23
Automated reconstruction of ancient languages using probabilistic models of sound change. Proc Natl Acad Sci U S A (2013) 1.23
Multicolored stain-free histopathology with coherent Raman imaging. Lab Invest (2012) 1.22
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells. Neuro Oncol (2008) 1.22
Clinal variation in phyB2, a candidate gene for day-length-induced growth cessation and bud set, across a latitudinal gradient in European aspen (Populus tremula). Genetics (2005) 1.19
Leaving paediatrics: the experience of service transition for young disabled people and their family carers. Health Soc Care Community (1998) 1.18
Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients. J Immunol (2010) 1.14
Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights. J Neurooncol (2011) 1.14
Molecular evolution and emergence of avian gammacoronaviruses. Infect Genet Evol (2012) 1.13
A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas. J Exp Med (2011) 1.13
Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma. J Neurooncol (2008) 1.13
Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging. Sci Rep (2013) 1.12
Medical management of brain tumor patients. Neurol Clin (2007) 1.09
Medical management of patients with brain tumors. J Neurooncol (2006) 1.09
Further studies on sex pheromones of female Lygus and related bugs: development of effective lures and investigation of species-specificity. J Chem Ecol (2014) 1.07
Hypertrophic olivary degeneration after resection of a cerebellar tumor. J Neurooncol (2008) 1.06
Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. J Proteome Res (2007) 1.06
Assessment of applicants to the veterinary curriculum using a multiple mini-interview method. J Vet Med Educ (2009) 1.04
Gene flow and selection on phenotypic plasticity in an island system of Rana temporaria. Evolution (2010) 1.04
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys (2010) 1.03
Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell Int (2014) 1.03
Primary care for children in the 21st century. BMJ (2005) 1.02
Morphological characteristics of brain tumors causing seizures. Arch Neurol (2010) 1.01
Longitudinal MRI evidence for decreased survival among periventricular glioblastoma. J Neurooncol (2010) 1.01
Leptomeningeal metastases in breast cancer. Am J Cancer Res (2013) 1.00
Genetic differentiation, clinal variation and phenotypic associations with growth cessation across the Populus tremula photoperiodic pathway. Genetics (2010) 1.00
Molecular pathogenesis of adult brain tumors and the role of stem cells. Neurol Clin (2007) 0.99
Heat treatment eliminates 'Candidatus Liberibacter asiaticus' from infected citrus trees under controlled conditions. Phytopathology (2013) 0.98
The hippocampal system mediates logical reasoning about familiar spatial environments. J Cogn Neurosci (2004) 0.97
Paraneoplastic limbic encephalitis presenting as a neurological emergency: a case report. J Med Case Rep (2010) 0.96
Magnetic resonance and fluorescence imaging of doxorubicin-loaded nanoparticles using a novel in vivo model. Nanomedicine (2010) 0.95
Specific exercises to treat pregnancy-related low back pain in a South African population. Int J Gynaecol Obstet (2011) 0.94
Isolation of rare tumor cells from blood cells with buoyant immuno-microbubbles. PLoS One (2013) 0.94
Children's health and development: approaches to early identification and intervention. Arch Dis Child (2013) 0.93
Urticarial hypersensitivity reaction caused by temozolomide. J Drugs Dermatol (2010) 0.93
Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs. J Transl Med (2014) 0.93
Glioma stem cell signaling: therapeutic opportunities and challenges. Expert Rev Anticancer Ther (2010) 0.92
Levetiracetam-induced interstitial nephritis in a patient with glioma. J Clin Neurosci (2011) 0.92
Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation. J Clin Oncol (2009) 0.92
Child protection--lessons from Victoria Climbié. BMJ (2003) 0.92
Defects in tongue papillae and taste sensation indicate a problem with neurotrophic support in various neurological diseases. Neuroscientist (2008) 0.92
Time between skin incision and delivery during cesarean. Int J Gynaecol Obstet (2013) 0.91
Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains. Bioconjug Chem (2012) 0.91
Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: an in vivo bioluminescence imaging study. Eur J Cancer (2010) 0.91
Novel approaches to treating leptomeningeal metastases. J Neurooncol (2011) 0.91
Malignant gliomas. Curr Neurol Neurosci Rep (2004) 0.91
A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2008) 0.90
Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM. Front Oncol (2013) 0.90
High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models. PLoS One (2013) 0.90
Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo. Neoplasia (2009) 0.90
Induction of apoptosis by enediyne antibiotic calicheamicin thetaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner. Oncogene (2003) 0.89
Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review. J Neurooncol (2011) 0.89
Direct recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AI. ACS Nano (2013) 0.89
CNS relapse in acute promyeloctyic leukemia. J Clin Oncol (2010) 0.88
Red-luminescent europium (III) doped silica nanoshells: synthesis, characterization, and their interaction with HeLa cells. J Biomed Opt (2011) 0.88
Safeguarding children: a call to action. Lancet (2008) 0.88